Kara-Balta:A new pharmaceutical manufacturing complex is set to be established in Kara-Balta, Chui region, as part of an investment initiative by Standard Pharm Group LLC. The project aims to enhance Kyrgyzstan's pharmaceutical industry and reduce reliance on imports.

According to 24.kg News Agency, the investment is valued at $41.2 million and is expected to generate approximately 300 jobs. The facility will produce medicines, gelatin capsules, and saline solutions.

The project was reviewed by Ravshanbek Sabirov, head of the National Investment Agency of Kyrgyzstan, who discussed construction progress and future development plans with the company. Sabirov emphasized the importance of training local students, offering them employment opportunities at the facility, and highlighted the significance of developing qualified specialists and professional growth for the youth.